Sneha Karmani, MBBS, MD
she/her/hers
Postdoctoral AssociateAbout
Titles
Postdoctoral Associate
Biography
Dr. Sneha Karmani is currently a Postdoctoral Associate in the Department of Psychiatry at Yale University School of Medicine. She works at the STEP program and is the Early Detection and Assessment Coordinator (EDAC) for DMHAS region 4.
Dr. Karmani is a board-certified Psychiatrist from India with over 10 years of clinical experience and has worked with multi-disciplinary teams in both clinical and research settings. She has worked as a consultant psychiatrist in India and as an International Psychiatry Fellow in adult in-patient care in the NHS, UK. Dr. Karmani has worked in Yoga and Mental Health research at the National Institute of Mental Health and Neurosciences, India where she was part of several research projects and grants. She is also interested in neurobiological research in severe mental disorders and early intervention services. She is passionate about patient care and engagement and believes individuals need to be viewed holistically to have a real impact on their quality of life.
Appointments
Psychiatry
Postdoctoral AssociatePrimary
Other Departments & Organizations
Education & Training
- Senior Resident
- National Institute of Mental Health And Neuro Sciences (2017)
- Junior Resident (non-PG)
- National Institute of Mental Health And Neuro Sciences (2014)
- Resident in Training
- Mental Health Center (2013)
- MD
- Mental Health Center, Diplomate of National Board-Psychiatry (2013)
- MBBS
- Lokmanya Tilak Municipal Medical College and General Hospital, Bachelor of Medicine, Bachelor of Surgery (2008)
Research
Publications
2024
The impact of early detection (ED) campaigns on care presentations: Beyond DUP reduction
Hazan H, Ferrara M, Riley S, Li F, Zhou B, Kline E, Gibbs-Dean T, Karmani S, Tayfur S, Tek C, Keshavan M, Srihari V. The impact of early detection (ED) campaigns on care presentations: Beyond DUP reduction. Schizophrenia Research 2024, 264: 457-461. PMID: 38266513, PMCID: PMC10923115, DOI: 10.1016/j.schres.2024.01.022.Peer-Reviewed Original ResearchConceptsCoordinated specialty careDuration of untreated psychosisImpact of early detectionEarly detectionEarly detection campaignsSpecialty careAdjustment scoresCampaign yearDetection campaignsMediation analysisEffects of EDRegression modelsCareUntreated psychosisPositive symptomsGAFPatientsSalutary effects
2023
Long-term Add-on Yoga Therapy Modulates Oxidative Stress Pathway and Offers Clinical Benefits in Major Depressive Disorder: A Randomized Controlled Trial.
Talukdar PM, Reddy PV, Bhargav PH, Subbanna M, Karmani S, Arasappa R, Subramanian GV, Kesavan M, Debnath M. Long-term Add-on Yoga Therapy Modulates Oxidative Stress Pathway and Offers Clinical Benefits in Major Depressive Disorder: A Randomized Controlled Trial. Int J Yoga 2023, 16: 180-184. PMID: 38463645, DOI: 10.4103/ijoy.ijoy_174_23.Peer-Reviewed Original Research
2021
Long-term add-on Yoga therapy offers clinical benefits in major depressive disorder by modulating the complement pathway: A randomized controlled trial.
Subbanna M, Talukdar PM, Abdul F, Debnath M, Reddy PV, Arasappa R, Venkatasubramanian G, Muralidharan K, Gangadhar BN, Bhargav PH, Karmani S. Long-term add-on Yoga therapy offers clinical benefits in major depressive disorder by modulating the complement pathway: A randomized controlled trial. Asian J Psychiatr 2021, 66: 102876. PMID: 34649098, DOI: 10.1016/j.ajp.2021.102876.Peer-Reviewed Original ResearchAdjunct yoga therapy: Influence on heart rate variability in major depressive disorder - A randomized controlled trial.
Gulati K, Bhargav PH, Reddy PV, Govindaraj R, Ravindran A, Gayathri D, Karmani SJ, Udupa K, Philip M, Debnath M, Bharath RD, Sathyaprabha TN, Venkatasubramanian G, Muralidharan K. Adjunct yoga therapy: Influence on heart rate variability in major depressive disorder - A randomized controlled trial. Asian J Psychiatr 2021, 65: 102832. PMID: 34592624, DOI: 10.1016/j.ajp.2021.102832.Peer-Reviewed Original ResearchImpact of a Course of Add-on Supervised Yoga on Cortical Inhibition in Major Depressive Disorder: A Randomized Controlled Trial.
Bhargav PH, Reddy PV, Govindaraj R, Gulati K, Ravindran A, Gayathri D, Karmani SJ, Udupa K, Venkatasubramanian G, Philip M, Debnath M, Bharath RD, Sathyaprabha TN, Gangadhar BN, Muralidharan Pi K. Impact of a Course of Add-on Supervised Yoga on Cortical Inhibition in Major Depressive Disorder: A Randomized Controlled Trial. Can J Psychiatry 2021, 66: 179-181. PMID: 32844672, DOI: 10.1177/0706743720953247.Peer-Reviewed Original Research In Press
2020
Yoga as monotherapy for the treatment of major depression - A case series.
Devi NA, Varambally S, Karmani S, Christopher R, Gangadhar BN. Yoga as monotherapy for the treatment of major depression - A case series. Asian J Psychiatr 2020, 53: 102177. PMID: 32505983, DOI: 10.1016/j.ajp.2020.102177.Peer-Reviewed Case Reports and Technical Notes
2018
Impact of lifestyle modification on some components of metabolic syndrome in persons with severe mental disorders: A meta-analysis.
Singh VK, Karmani S, Malo PK, Virupaksha HG, Muralidhar D, Venkatasubramanian G, Muralidharan K. Impact of lifestyle modification on some components of metabolic syndrome in persons with severe mental disorders: A meta-analysis. Schizophr Res 2018, 202: 17-25. PMID: 30539768, DOI: 10.1016/j.schres.2018.06.066.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
2016
Yoga and physical exercise - a review and comparison.
Govindaraj R, Karmani S, Varambally S, Gangadhar BN. Yoga and physical exercise - a review and comparison. Int Rev Psychiatry 2016, 28: 242-53. PMID: 27044898, DOI: 10.3109/09540261.2016.1160878.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsDesigning and validation of a yoga-based intervention for obsessive compulsive disorder.
Bhat S, Varambally S, Karmani S, Govindaraj R, Gangadhar BN. Designing and validation of a yoga-based intervention for obsessive compulsive disorder. Int Rev Psychiatry 2016, 28: 327-33. PMID: 27117898, DOI: 10.3109/09540261.2016.1170001.Peer-Reviewed Original ResearchClinical efficacy and safety of repetitive transcranial magnetic stimulation in acute bipolar depression.
McGirr A, Karmani S, Arsappa R, Berlim MT, Thirthalli J, Muralidharan K, Yatham LN. Clinical efficacy and safety of repetitive transcranial magnetic stimulation in acute bipolar depression. World Psychiatry 2016, 15: 85-6. PMID: 26833619, DOI: 10.1002/wps.20300.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements